A major pharmaceutical company which alleges trademark infringement has been refused an injunction preventing the roll-out by a rival of an inhaler for asthmatics. The injunction was sought pending ...
Mumbai: Glenmark Pharmaceuticals Ltd said on Friday that it has received regulatory approval for the generic version of GlaxoSmithKline Plc’s Seretide Accuhaler in the Nordic region, which includes ...
The New England Journal of Medicine has published a clinical trial showing that Novartis' Ultibro Breezhaler outshone GlaxoSmithKline's Seretide on reducing COPD flare-ups, which could challenge the ...
Seretide/Advair is GSK’s best-selling drug, and the line was extended in 2003 when the European Union approved the higher-dose 500 Accuhaler for the symptomatic treatment of severe COPD, i.e., ...
The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...
Mylan becomes the first company to market a generic version of the UK's number one prescribed long-acting beta2-agonist + inhaled corticosteroid pressurized metered-dose inhaler asthma therapy[1],[2] ...
The generic drug, montelukast should be offered to people ahead of combination inhalers such as GlaxoSmithKline's Seretide, in a bid to save the NHS millions of pounds, according to draft guidance ...
Seretide diskus, a combination inhaler and the world's biggest selling anti-asthmatic medication from the stable of GlaxoSmithkline Pharmaceutical Nigeria PLC (GSK), is set to be launched into the ...
AN URGENT inhaler recall has been issued for asthma sufferers with GPs warning they are failing to deliver the correct doses of medication, putting people's lives "at risk". The Medicines and ...
LONDON, July 9 (Reuters) - GlaxoSmithKline Plc has won a licence extension in Europe for Seretide, allowing its top-selling inhaler product to be used in a wider population of patients with the lung ...
Mylan becomes the first company to market a generic version of the UK's number one prescribed long-acting β2-agonist + inhaled corticosteroid pressurized metered-dose inhaler asthma therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results